Home Medicine Haptoglobin Polymorphism and Body Iron Stores
Article
Licensed
Unlicensed Requires Authentication

Haptoglobin Polymorphism and Body Iron Stores

  • and
Published/Copyright: June 1, 2005
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 40 Issue 3

Abstract

In humans the iron status is influenced by environmental and genetic factors. Among them, the genetic polymorphism of the hemoglobin (Hb)-binding plasma protein haptoglobin (Hp) has been shown to affect iron turnover. The best known biological function of Hp is capture of free Hb in plasma to allow hepatic recycling of heme iron and to prevent kidney damage during hemolysis. In healthy males, but not in females, the Hp 2-2 phenotype is associated with higher serum iron, higher transferrin saturation, and higher ferritin than Hp 1-1 and 2-1. Moreover, serum ferritin correlates with monocyte L-ferritin content, which is also highest in Hp 2-2 subjects due to endocytosis of multimeric Hb-Hp 2-2 complexes by the recently identified Hb scavenger receptor CD163 in macrophages. This iron delocalization pathway, occurring selectively in Hp 2-2 subjects, has important biological and clinical consequences. The Hp polymorphism is related to the prevalence and the outcome of various pathological conditions with altered iron metabolism such as hemochromatosis, infections, and atherosclerotic vascular disease.

:
Published Online: 2005-06-01
Published in Print: 2002-04-10

Copyright © 2002 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. New Developments in Clinical Chemistry and Laboratory Medicine as Documented by EUROMEDLAB 2001 the 14th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine, Prague, May 2631, 2001
  2. Haptoglobin Polymorphism and Body Iron Stores
  3. Immunohistochemistry in the Evaluation of Spermatogenesis and Sertoli Cell's Maturation Status
  4. Study of Therapy Resistance in Cancer Cells with Functional Proteome Analysis
  5. Proposition of an Aging Indicator from General Health Examination in France
  6. Comparison of Plasma Cardiac Troponins T and I in Chronically Hemodialyzed Patients in Relation to Cardiac Status and Age
  7. Medical and Economic Outcomes of Point-of-Care Testing
  8. Are Laboratory Investigations Recommended in Current Medical Practice Guidelines Supported by Available Evidence?
  9. New Aspects on Angiotensin-Converting Enzyme: from Gene to Disease
  10. Oxypurines, Protein, Glucose and the Functional State of Blood Vasculature Are Markers of Renal Calcium Stone-forming Processes? Observations in Men with Idiopathic Recurrent Calcium Urolithiasis
  11. Long-Chain Polyunsaturated Fatty Acids in Rat Maternal Milk, Offspring Brain and Peripheral Tissues in Essential Fatty Acid Deficiency
  12. Simultaneous Quantification of Sirolimus, Everolimus, Tacrolimus and Cyclosporine by Liquid Chromatography-Mass Spectrometry (LC-MS)
  13. Pancreatic Phospholipase A2 Activity in Acute Pancreatitis: a Prognostic Marker for Early Identification of Patients at Risk
  14. Serum Cytokeratin Fragment 21.1 (CYFRA 21.1) as Tumour Marker for Breast Cancer: Comparison with Carbohydrate Antigen 15.3 (CA 15.3) and Carcinoembryonic Antigen (CEA)
  15. Serum Cholesterol Levels in Neutropenic Patients with Fever
  16. Evaluation of Two Mg2+-Selective Electrodes by Means of a Flow-Through Device
  17. The Management of Clinical Laboratories in Europe: a FESCC Survey
  18. Meetings and Awards
Downloaded on 19.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2002.035/html
Scroll to top button